Category Archives: SPBIO

Biotech (channel) Breakdown

September 15, 2026 By in $SPSIBI, Biotech, IBB, IBB-26-05, SPBIO, XBI, XBI-26-11 Leave a comment

Off The Cliff?

We won’t know for sure, until a long time from now … when it’s all over (not advice, not a recommendation).

Yesterday’s action in biotech IBB, posted a new daily high, while at the same time, XBI moved higher but was unable to post a new high.

Trade Action: IBB-26-05, was exited with profit and the short re-established as XBI-26-11 (not advice, not a recommendation).

As the chart shows (blue arrows), that XBI short was increased during today’s session.

Biotech XBI, Daily

We’re still at the far-right side, the ‘supply side’.

If the entire channel is in-effect, the ‘demand side’, is a long way away.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech in ‘Sequence’

September 11, 2026 By in Biotech, IBB, SPBIO, $SPSIBI, IBB-26-05 Leave a comment

Fibonacci Sequence

As far as the markets are concerned, when ‘everybody’ figures out there’s a pattern going on, that pattern morphs into something else.

For now, as the chart shows, it looks like biotech IBB, is ‘respecting’ a Fibonacci sequence (not advice, not a recommendation).

The chart also shows a potential channel.

Biotech IBB, Daily

So far, IBB is pivoting right at, or adjacent to sequence numbers (not advice, not a recommendation).

Next up, would be number ’21’.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech follows Amgen … Down

September 8, 2026 By in Biotech, IBB, AMGN, SPBIO, $SPSIBI, XBI, XBI-26-10, IBB-26-05 Leave a comment

IBB, Below Support

Amgen was whacked for a -10.08% loss during today’s session.

Biotech IBB, XBI, followed suit; down -2.17% and -1.15%, respectively.

Both indexes retraced during the day; it was noted XBI’s retrace was 50%, while IBB’s retrace as 38%.

Therefore, the trading response was to close short-trade XBI-26-10 (for profit), re-establish that short via IBB, as IBB-26-05 (not advice, not a recommendation).

Note in the chart above, the last time IBB pushed below support, it was in spring position and moved higher the next three sessions.

Markets tend to alternate.

Let’s see what happens next.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Moderna ‘Stretched’

September 5, 2026 By in Biotech, MRNA, SPBIO, XBI, XBI-26-10 Leave a comment

The Most, Ever

The effect of Moderna’s single day +176.97% move, can be directly seen in biotech XBI gaining +5.90%, the same day.

Since then, it’s been just over two-weeks and already, Wall St. has ‘cooled‘ to Moderna.

You can’t make this up. 🙂

With that said, and from a market behavior standpoint alone, wide high-volume price bars, tend to be tested (not advice, not a recommendation).

Moderna MRNA, Weekly

With MRNA slamming into resistance, highest volume, widest bar, ever, sort of says ‘Ruh Roh‘.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech at The Edge (again)

September 3, 2026 By in Biotech, LABD, CVNA, SPBIO, KMX, $SPSIBI, XBI, LABD-26-10, ABNB, XBI-26-10 1 Comment

Is The Top, In?

Whether it’s Biotech XBI, Airbnb, CarMax or Carvana, trade set-ups are being worked that take place at the ‘edge of congestion.’

The last update on XBI, was here, August 24th, nine trading days ago.

The short, LABD-26-10 was immediately stopped out at the next session.

The index labored on, grinding in a range while posting a bearish MACD divergence on daily and weekly.

All of which, brings us to now.

The chart shows today’s action could not close above the resistance area posted back in July (not advice, not a recommendation).

There’s been no new daily low (yet).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech … Breakout Bust

August 30, 2026 By in Biotech, IBB, SPBIO

Wedge ‘Throw-Over’

‘When price action heads south, bad news comes out.’

The chart below, shows we’re at a nascent reversal (not advice, not a recommendation).

Once a reversal takes hold and the money dries up, it’s likely to get very interesting.

Popcorn at the ready. 🙂

Biotech IBB, Daily Close

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech Spotlight

August 24, 2026 By in $SPSIBI, Biotech, Ed Dowd, Greg Hunter, LABD, LABD-26-10, SPBIO, Speck-Effect, Spring-to-Up-Thrust, The Speck, XBI, ZeroHedge 1 Comment

Potential Set-Up

Over the weekend, Greg Hunter released his latest interview with Ed Dowd, link here.

ZeroHedge subsequently picked up that feed, link here.

As is typical with ZeroHedge, the comments are a veritable gold-mine. In the like above, they don’t disappoint.

With XBI, we have our repeating pattern, link here.

Stay Tuned

Charts by StockCharts, TC2000

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech … Test & Reverse

May 1, 2026 By in $SPSIBI, Biotech, SPBIO, Spring-to-Up-Thrust, Up-Thrust, XBI, XBI-26-05

Pivot Lower

This week, biotech XBI, broke below support and then came back to test.

Today printed a new daily low (and closed lower), indicating the test may be complete.

Short trade: XBI-26-05, opened late in the session with a stop just above the day’s high (not advice not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Downside Breakaway … SOXX

March 21, 2026 By in $SPSIBI, Artificial Intelligence, Biotech, DIA, Dow 30, Nasdaq, NVDA, QQQ, SOXX, SPBIO, SPY, Wyckoff, XBI, XBI-26-04, YouTube Black Swan 2 Comments

Some Gaps, Never Filled

The day after the SOXX, topped on February 25th, was, this update.

In the case of Nvidia, it never printed or closed above the high reached on that day.

Well, the SOXX never made it back either.

Then, March 3rd, we have what looks like a ‘breakaway’ gap.

There’ve been at least two attempts to close that gap.

One of those attempts, a Wyckoff ‘spring’ set-up, which may have failed (not advice, not a recommendation).

Semiconductors SOXX, Daily

Other markets have rolled over as well; the Dow, S&P, the Qs, Biotech and so on (not advice, not a recommendation).

This just out, shows the typical response to an oil price shock, link here.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech Confirms (so far)

March 19, 2026 By in $SPSIBI, Biotech, SPBIO, XBI, XBI-26-04

Downtrend Intact

Today’s action moved up, contacting the right side (supply side) trendline from yesterday’s update; then, pulled back.

For the short position, XBI-26-04. shown, the stop is just above today’s session high (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279